Colm Keane

2.8k citations

84 papers · 1.4k indexed · h-index 21

Impact in

Pathology and Forensic Medicine top 2%
- Lymphoma Diagnosis and Treatment
Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- CAR-T cell therapy research

Papers in ⓘ

Pathology and Forensic Medicine 62
- Lymphoma Diagnosis and Treatment 62
Oncology 55
- Cancer Immunotherapy and Biomarkers 30
- CAR-T cell therapy research 23
- Viral-associated cancers and disorders 11

Co-authors: Maher K. Gandhi (43 shared papers)Frank Vari (17 shared papers)Kimberley Jones (10 shared papers)Jamie P. Nourse (10 shared papers)Devinder Gill (13 shared papers)Joshua W.D. Tobin (20 shared papers)Pauline Crooks (13 shared papers)Dipti Talaulikar (14 shared papers)
Journals: Blood (24 papers)Journal of Clinical Oncology (8 papers)British Journal of Haematology (5 papers)Blood Advances (4 papers)Clinical Cancer Research (3 papers)
Partner nations: Australia United States Germany

In The Last Decade

Colm Keane

77 papers receiving 1.4k citations

Peers

Countries citing papers authored by Colm Keane

Since Specialization

Citations

This map shows the geographic impact of Colm Keane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colm Keane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colm Keane more than expected).

Fields of papers citing papers by Colm Keane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colm Keane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colm Keane. The network helps show where Colm Keane may publish in the future.

Co-authors

The 25 scholars most cited alongside Colm Keane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Colm Keane Line = papers co-authored together Colm Keane links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL Blood ·Frank Vari, David Arpon, Colm Keane, Mark Hertzberg, Dipti Talaulikar, Sanjiv Jain, Qingyan Cui, Erica Han, Joshua W.D. Tobin, Robert Bird, Donna Cross, Annette Hernandez, Clare Gould, Simone Birch, Maher K. Gandhi	2018	231
2	Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin Lymphoma Clinical Cancer Research ·Kimberley Jones, Jamie P. Nourse, Colm Keane, Atul Bhatnagar, Maher K. Gandhi	2013	107
3	Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma Clinical Cancer Research ·Kimberley Jones, Frank Vari, Colm Keane, Pauline Crooks, Jamie P. Nourse, Louise Seymour, David Gottlieb, David Ritchie, Devinder Gill, Maher K. Gandhi	2012	83
4	CD4⁺ Tumor infiltrating lymphocytes are prognostic and independent of R‐IPI in patients with DLBCL receiving R‐CHOP chemo‐immunotherapy American Journal of Hematology ·Colm Keane, Devinder Gill, Frank Vari, Donna J. Cross, Lynn Griffiths, Maher K. Gandhi	2013	70
5	Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study The Lancet Haematology ·Colm Keane, Frank Vari, Mark Hertzberg, Kim‐Anh Lê Cao, Michael R. Green, Erica Han, John F. Seymour, Rodney J. Hicks, Devinder Gill, Pauline Crooks, Clare Gould, Kimberley Jones, Lyn R. Griffiths, Dipti Talaulikar, Sanjiv Jain, Joshua W.D. Tobin, Maher K. Gandhi	2015	67
6	The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma Clinical Cancer Research ·Colm Keane, Clare Gould, Kimberley Jones, David Hamm, Dipti Talaulikar, Jonathan Ellis, Frank Vari, Simone Birch, Erica Han, Peter Wood, Kim‐Anh Lê Cao, Michael R. Green, Pauline Crooks, Sanjiv Jain, Joshua W.D. Tobin, Raymond J. Steptoe, Maher K. Gandhi	2016	63
7	EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2 Blood ·Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West, Muhammed B. Sabdia, Soi Cheng Law, Jay Gunawardana, Frank Vari, Sally Mujaj, Gayathri Thillaiyampalam, Cameron Snell, Madeline Gough, Colm Keane, Maher K. Gandhi	2019	50
8	Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions British Journal of Haematology ·Charlotte Lees, Colm Keane, Maher K. Gandhi, Jay Gunawardana	2019	50
9	Stem Cell–based Therapies for Sepsis Anesthesiology ·Colm Keane, Mirjana Jerkić, John G. Laffey	2017	49
10	A Comprehensive Analysis of the Cellular and EBV-Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV-Associated Tumors American Journal of Transplantation ·Susanne Fink, Maher K. Gandhi, Jamie P. Nourse, Colm Keane, Kimberley Jones, Pauline Crooks, Korinna Jöhrens, Agnieszka Korfel, Helmut H. Schmidt, S. Neumann, Andreas Tiede, Ulrich Jäger, Ulrich Dührsen, R. Neuhaus, Martin Dreyling, K Borchert, T Südhoff, Hanno Riess, Ioannis Anagnostopoulos, Ralf Ulrich Trappe	2014	42
11	CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy. PubMed ·Colm Keane, Devinder Gill, Frank Vari, Donna J. Cross, Lyn R. Griffiths, Maher K. Gandhi	2013	41
12	The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma European Journal Of Haematology ·Colm Keane, Joshua W.D. Tobin, Jay Gunawardana, Santiyagu M. Savarimuthu Francis, Grace Gifford, Sara Gabrielli, Anthony J. Gill, William Stevenson, Dipti Talaulikar, Clare Gould, Sanjiv Jain, Simone Birch, Mark Hertzberg, Maher K. Gandhi	2019	37
13	The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma Clinical & Experimental Immunology ·Kimberley Jones, Leesa Wockner, R.M. Brennan, Colm Keane, Pratip K. Chattopadhyay, Mario Roederer, David A. Price, David K. Cole, Brekhna Hassan, Konrad Beck, David Gottlieb, David Ritchie, John F. Seymour, Frank Vari, Pauline Crooks, Scott R. Burrows, Maher K. Gandhi	2015	33
14	Tumor‐specific but not nonspecific cell‐free circulating DNA can be used to monitor disease response in lymphoma American Journal of Hematology ·Kimberley Jones, Jamie P. Nourse, Colm Keane, Pauline Crooks, David Gottlieb, David Ritchie, Devinder Gill, Maher K. Gandhi	2011	28
15	Homozygous FCGR3A‐158V alleles predispose to late onset neutropenia after CHOP‐R for diffuse large B‐cell lymphoma Internal Medicine Journal ·Colm Keane, Jamie P. Nourse, Pauline Crooks, Do Nguyen-Van, Howard Mutsando, Peter Mollee, Rod A. Lea, Maher K. Gandhi	2011	24
16	Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B‐cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance British Journal of Haematology ·Joel Wight, Mimi Yue, Colm Keane, Anna Johnston, Kim Linton, Collin K. Chin, Shin Hnin Wai, Dipti Talaulikar, Robin Gasiorowski, Chan Y. Cheah, Gareth P. Gregory, Michael Dickinson, Adrian Minson, Caitlin Coombes, Matthew Ku, Stephanie Lam, Eliza A. Hawkes	2019	23
17	Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment Current Opinion in Immunology ·Louisa Alim, Colm Keane, Fernando Souza-Fonseca-Guimarães	2023	22
18	High‐resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non‐hodgkin's lymphoma Genes Chromosomes and Cancer ·Carlos Aya‐Bonilla, Michael R. Green, Emily T. Camilleri, Miles C. Benton, Colm Keane, Paula Marlton, Rod A. Lea, Maher K. Gandhi, Lyn R. Griffiths	2013	21
19	Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples Journal of Virological Methods ·Jamie P. Nourse, Pauline Crooks, Colm Keane, Do Nguyen-Van, Sally Mujaj, Nathan Ross, Kimberley Jones, Frank Vari, Erica Han, Ralf Ulrich Trappe, Susanne Fink, Maher K. Gandhi	2012	21
20	A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival Oncotarget ·Colm Keane, Joshua W.D. Tobin, Dipti Talaulikar, Michael R. Green, Pauline Crooks, Sanjiv Jain, Maher K. Gandhi	2018	21

About Colm Keane

Colm Keane is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Neurology, having authored 84 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (62 papers), Cancer Immunotherapy and Biomarkers (30 papers), CAR-T cell therapy research (23 papers), Immune Cell Function and Interaction (18 papers), Chronic Lymphocytic Leukemia Research (12 papers), Viral-associated cancers and disorders (11 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (645 citations), Oncology (778 citations), Immunology (586 citations), Genetics (199 citations) and Cancer Research (204 citations). Colm Keane has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Maher K. Gandhi, Frank Vari, Kimberley Jones, Jamie P. Nourse, Devinder Gill, Joshua W.D. Tobin, Pauline Crooks, Dipti Talaulikar, Sanjiv Jain and Erica Han. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Blood Advances and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact